Astera Labs (NASDAQ:ALAB) Issues Earnings Results

Key Points

• Earnings beat: Astera Labs reported EPS of $0.58 (vs. $0.51 est.) and revenue of $270.58M (vs. $249.46M), with a net margin of 27.5% and ROE of 13.48%.
• Stock reaction and valuation: Shares traded down ~2.6% to $182.86 on above-average volume; the company carries a market cap of $30.89B and a high P/E of 164.74.
• Heavy insider selling: CEO and a director sold large blocks (CEO 90,459 shares at ~$144.69; director 150,000 at ~$166.18), and insiders sold 576,936 shares worth about $87.4M over the past three months.

Astera Labs (NASDAQ:ALAB - Get Free Report) issued its quarterly earnings results on Tuesday. The company reported $0.58 earnings per share for the quarter, topping the consensus estimate of $0.51 by $0.07, FiscalAI reports. Astera Labs had a net margin of 27.50% and a return on equity of 13.48%. The company had revenue of $270.58 million during the quarter, compared to analysts' expectations of $249.46 million.

Astera Labs Trading Down 2.6%

Shares of NASDAQ:ALAB traded down $4.81 during mid-day trading on Tuesday, reaching $182.86. The stock had a trading volume of 6,968,450 shares, compared to its average volume of 5,081,802. The company has a market cap of $30.89 billion, a P/E ratio of 164.74, a price-to-earnings-growth ratio of 2.32 and a beta of 1.51. Astera Labs has a 1 year low of $47.13 and a 1 year high of $262.90. The business's 50 day moving average price is $164.63 and its 200 day moving average price is $174.20.

Insider Buying and Selling at Astera Labs

In related news, CEO Jitendra Mohan sold 90,459 shares of Astera Labs stock in a transaction dated Monday, November 17th. The shares were sold at an average price of $144.69, for a total transaction of $13,088,512.71. Following the completion of the transaction, the chief executive officer directly owned 2,080,418 shares of the company's stock, valued at approximately $301,015,680.42. The trade was a 4.17% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Manuel Alba sold 150,000 shares of the firm's stock in a transaction that occurred on Monday, December 1st. The stock was sold at an average price of $166.18, for a total transaction of $24,927,000.00. Following the transaction, the director directly owned 1,574,498 shares in the company, valued at approximately $261,650,077.64. This trade represents a 8.70% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 576,936 shares of company stock valued at $87,409,540. Insiders own 12.50% of the company's stock.

Institutional Trading of Astera Labs

Large investors have recently made changes to their positions in the business. Great Valley Advisor Group Inc. increased its position in shares of Astera Labs by 2.2% in the second quarter. Great Valley Advisor Group Inc. now owns 4,119 shares of the company's stock valued at $372,000 after buying an additional 90 shares in the last quarter. National Bank of Canada FI boosted its position in shares of Astera Labs by 159.0% during the 3rd quarter. National Bank of Canada FI now owns 202 shares of the company's stock valued at $39,000 after acquiring an additional 124 shares during the last quarter. Prosperity Wealth Management Inc. grew its stake in shares of Astera Labs by 4.1% in the 3rd quarter. Prosperity Wealth Management Inc. now owns 4,300 shares of the company's stock valued at $842,000 after buying an additional 168 shares during the period. Wexford Capital LP acquired a new stake in shares of Astera Labs during the 3rd quarter worth about $39,000. Finally, Northwestern Mutual Wealth Management Co. boosted its position in shares of Astera Labs by 81.8% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 600 shares of the company's stock worth $100,000 after buying an additional 270 shares during the period. 60.47% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several analysts have recently issued reports on the company. Weiss Ratings reissued a "hold (c-)" rating on shares of Astera Labs in a report on Wednesday, January 21st. JPMorgan Chase & Co. boosted their target price on shares of Astera Labs from $180.00 to $215.00 and gave the company an "overweight" rating in a research report on Wednesday, November 5th. Wall Street Zen cut shares of Astera Labs from a "buy" rating to a "hold" rating in a research report on Tuesday, November 11th. TD Cowen reaffirmed a "hold" rating on shares of Astera Labs in a research report on Wednesday, November 5th. Finally, Northland Securities boosted their price target on shares of Astera Labs from $175.00 to $195.00 and gave the company an "outperform" rating in a research report on Tuesday, December 9th. Fifteen research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company's stock. According to data from MarketBeat, Astera Labs currently has a consensus rating of "Moderate Buy" and a consensus price target of $190.63.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.